Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB1/CB2 receptors-Reference-Cited by-同舟云学术

Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB1/CB2 receptors

Published:2002-03 Issue:1-3 Volume:439 Page:83-92
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Brooks Jason W.,Pryce Gareth,Bisogno Tiziana,Jaggar Siân I.,Hankey Deborah J.R.,Brown Peter,Bridges Daniel,Ledent Catherine,Bifulco Maurizio,Rice Andrew S.C.,Di Marzo Vincenzo,Baker David

Publisher

Elsevier BV

Subject

Pharmacology

Reference40 articles.

1. Genetic analysis of experimental allergic encephalomyelitis in mice;Baker;J. Immunol.,1995

2. Cannabinoids control spasticity and tremor in a multiple sclerosis model;Baker;Nature,2000

3. Endocannabinoids control spasticity in a multiple sclerosis model;Baker;FASEB J.,2001

4. Role of the endogenous cannabinoid system in the formalin test of persistent nociception in the rat;Beaulieu;Eur. J. Pharmacol.,2000

5. Evidence for a new G-protein-coupled cannabinoid receptor in mouse brain;Breivogel;Mol. Pharmacol.,2001

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Potential of Capsaicin in Various Neurodegenerative Diseases with Special Focus on Nrf2 Signaling;Current Pharmaceutical Biotechnology;2024-10

2. Cannabis and Multiple Sclerosis;Plant-Based Therapeutics, Volume 1;2023

3. Comparison of the Anticancer Effects of Arvanil and Olvanil When Combined with Cisplatin and Mitoxantrone in Various Melanoma Cell Lines—An Isobolographic Analysis;International Journal of Molecular Sciences;2022-11-16

4. Pathogenesis and management of multiple sclerosis revisited;Disease-a-Month;2022-10

5. Targeting CB2 and TRPV1: Computational Approaches for the Identification of Dual Modulators;Frontiers in Molecular Biosciences;2022-02-25